Director, PCR Enzymes & Stem Cell Marketing
Takara Bio USA, Inc.
Dr. Liz Quinn is Director, PCR Enzymes and Stem Cell Marketing at Takara Bio USA, Inc. following nearly 20 years of research and commercial experience in the life science and biotechnology industries. She is a molecular and cell biologist by training, and obtained her PhD from Wayne State University, followed by a 3 year post-doctoral fellowship at Stanford University. Dr. Quinn joined Clontech Laboratories, Inc. in 2001 and held varied and increasing responsibility within Operations, R&D and Marketing. In 2008, she joined DiscoverX Corporation and managed the GPCR drug discovery business. After leaving DiscoverX in 2014, she served as founder and CEO for a new life science and drug discovery-focused marketing consulting company based in Northern CA. Then in 2015, Liz joined Takara Bio USA where she has focused on launching a new stem cell product portfolio which includes human iPS and ES-derived lines, culture systems and services for directed differentiation and gene editing. Liz has long-standing involvement in the launch of novel technology platforms and development of innovative product portfolios supporting drug discovery. More recently, she has been responsible for establishing the Takara Bio’s PCR/qPCR reagents and high- throughput SmartChip Real Time PCR instrument in the clinical research market. In addition to her current role, Liz previously served as a board member of ELRIG, the European Laboratory Research and Innovation Group, and served as their Scientific Programme Director between 2014 – 2016.
Tuesday, January 28
2:00 PM – 2:45 PM